LIVEN reported a significant loss after taxation of Rs 28.21 billion, indicating serious financial distress
Filed as: Financial Results for the half year ended December 31, 2025
Summary
LIVEN reported a significant loss after taxation of Rs 28.21 billion, indicating serious financial distress.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | 34.56 | 17.13 | +101.8% |
| Gross Profit | 5.91 | 2.4 | +146.3% |
| Operating Loss | 8.43 | 4.9 | +72.0% |
| Net Loss After Taxation | 28.21 | 4.9 | +475.7% |
| Total Assets | 811.17 | 822.9 | -1.4% |
| Total Equity | 631.91 | 633.86 | -0.3% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue decreased to Rs 34.56 million from Rs 17.13 million, reflecting a decline in sales performance.
- Operating loss widened to Rs 8.43 million from Rs 4.90 million, indicating deteriorating operational efficiency.
- Net loss after taxation reached Rs 28.21 billion, a stark increase from the previous loss of Rs 4.90 million.
Liven Pharma Limited (LIVEN) on Nafa
Last price Rs 39.19 · Pharmaceuticals · You can own LIVEN shares from your phone.
More LIVEN announcements
- NoticeGeneral Meetings / Briefing Sessions
- NoticeNotice of Corporate Briefing Session
- Financial resultLiven Pharma Limited reported a significant loss of Rs 7.37 million for the period ended September 30, 2026Filed as: Financial Results for the Quarter Ended September 30-2026
- NoticeBOARD MEETING FOR 1st Quarter Financials 2027
- NoticeCertified True Copy of Resolution Passed in Annual General Meeting Held 26th October 2026
- NoticeCorrection Clarification Regarding Annual Report 2026
Source: Liven Pharma Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.